BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

BIOL 2.56 +0.03 (1.19%)
price chart
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
Short Interest of BIOLASE Inc Drops by -5.7%
BIOLASE Inc (NASDAQ:BIOL) reported a drop of 5.7% or 203,199 shares in its short interest. The short figure came in at 7.2% of the total floats.
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
BIOLASE Inc (BIOL): Biolase: What Will Happen Next ?
Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks. Two days ago I highlighted an ongoing plunge that had already begun at Biolase (NASDAQ:BIOL). Prior to my article, the shares had already ...
Related articles »  
BIOLASE Inc (BIOL) news: Biolase management faces proxy fight
Investment fund Oracle Partners battles Biolase (BIOL) Chairman Frederico Pignatelli for control of the firm. The fund seeks to install four new directors in an effort to improve the company's financial performance.
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.  PR Newswire (press release)
Related articles »  
BIOLASE SHAREHOLDER ALERT - Andrews & Springer LLC is Investigating ...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating the Board of Directors of Biolase, Inc. ("Biolase" or the "Company") for possible corporate misconduct and violations ...
Related articles »  
Biolase (BIOL) Reports $35M Private Placement
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that investors including Jack W. Schuler, Oracle Partners, L.P.
BIOLASE to Raise $35 Million from Institutional and Individual Investors in ...  MarketWatch
Biolase to raise $35 million from institutional and individual investors in ...  Dentistry IQ
Related articles »  
Update on Biolase - Oracle Partners fight for control (BIOL)
The Vice Chancellor of the Court of Chancery of the State of Delaware rules that shareholder Oracle Partners-backed Paul Clark's February 28, 2014 election to the board of directors is valid.
Related articles »  
BIOLASE Inc (BIOL) news: BIOLASE's CEO Discusses Q4 2013 Results ...
Ladies and gentlemen, thank you for standing by, and welcome to the BIOLASE 2013 Fourth Quarter and Year End Results Conference Call.
BIOLASE Reports 2013 Fourth Quarter, Year End Results  Marketwired (press release)
Related articles »